F/m Emerald Life Sciences Innovation ETF Price & Performance (LFSC)

Eternal Ltd stock climbed more than 5% on both the BSE and NSE today, closing at Rs 239.8 and Rs 239.5, respectively. Trading volumes were robust, with over 28 million shares exchanged. The company's stock has posted a 23.8% gain in the past year, reflecting ongoing investor enthusiasm.1

Several Innovator Premium Income ETFs, including APRD, APRQ, HAPR, and XDAP, were liquidated on April 9, 2025. Shareholders received cash payouts based on the respective net asset values. The closures highlight ongoing volatility in the ETF marketplace and underscore the importance of monitoring fund status closely.2

Morningstar’s latest review of the Emerald Growth C Fund notes solid management and a sound investment process, but highlights high fees as a significant drawback. With a 1.76% expense ratio, the fund ranks among the most expensive in its category, potentially limiting returns for investors despite its performance track record.3